← Open Payments lookup

KATHI PRICE: Open Payments

NPI 1477656023 · COEBURN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$830 in 23 payments from 6 companies in 2025. Trend: 2023 $1,021 · 2024 $579 · 2025 $830

Food & beverage: $830
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$232
AstraZeneca Pharmaceuticals LP7$227
Gilead Sciences, Inc.4$151
Novo Nordisk Inc3$148
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$36
ABBVIE INC.2$36

Products named: CAPLYTA, Ozempic, AIRSUPRA, Epclusa, FARXIGA, XIFAXAN, UBRELVY, VRAYLAR.

Industry payments across VA — which companies pay providers there.